A new concept of drought feeling against the meteorological drought.

Drought is a natural disaster that causes much damage to the communities. Recently, water demand has been increasing sharply due to the population growth and the development process. By approaching the amount of water demand to the natural supplies, any decrease in the water supply may lead to a considerable negative socio-economic consequence.

The optimal alternative for quantifying reference evapotranspiration in climatic sub-regions of Bangladesh.

Reference evapotranspiration (ET) is a basic element for hydrological designing and agricultural water resources management. The FAO56 recommended Penman-Monteith (FAO56-PM) formula recognized worldwide as the robust and standard model for calculating ET. However, the use of the FAO56-PM model is restricted in some data-scarce regions like Bangladesh.

A novel equation for longitudinal dispersion coefficient prediction based on the hybrid of SSMD and whale optimization algorithm.

The purpose of the present paper is improving the accuracy of existing formulas for the longitudinal dispersion coefficient (LDC) prediction based on a novel and simple meta-heuristic optimization method called Whale Optimization Algorithm (WOA). Although several existing formulas calculate LDC in the rivers based on the hydraulic and hydrodynamic specifications, most of them have significant errors in confronting extensive field data. In this study, comprehensive field data, including the geometrical and hydraulic properties of different rivers in the world, were adopted to build a reliable model.

COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.

This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.

COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.

Objectives: The regenerative potential of bone marrow-derived mononuclear cells (MNCs) and CD133+ stem cells in the heart varies in terms of their pro-angiogenic effects. This phase II/III, multicenter and double-blind trial is designed to compare the functional effects of intramyocardial autologous transplantation of both cell types and placebo in patients with recent myocardial infarction (RMI) post-coronary artery bypass graft.

Materials And Methods: This was a phase II/III, randomized, double-blind, placebo-controlled trial COMPARE CPM-RMI (CD133, Placebo, MNCs - recent myocardial infarction) conducted in accordance with the Declaration of Helsinki that assessed the safety and efficacy of CD133 and MNCs compared to placebo in patients with RMI.

Endovascular treatment of aortobronchial fistula secondary to coronary artery bypass graft (CABG).

Aortobronchial fistula (ABF) is a rare and late complication of cardiac surgery. If untreated, mortality rate is approximately 100% secondary to exsanguinations haemoptysis. Early diagnosis and treatment are essential for successful management.

Closure of a muscular ventricular septal defect using the Amplatzer ventricular occluder.

Surgical closure of ventricular septal defect is safe, however, the inherent risks associated with cardiopulmonary bypass and the potential early and late postsurgical complications including complete heart block, arrhythmias, postpericardiotomy syndrome, and rare deaths have led physicians to prefer transcatheter occlusion technique for closure of such defects. The use of Amplatzer muscular ventricular septal defect occluder is safe and associated with a higher success rate than other previously used devices. For the first time in Iran, we report an 18-year-old patient with ventricular septal defect who was successfully treated using the Amplatzer ventricular septal defect occluder.

Intense migraines secondary to percutaneous closure of atrial septal defects.

In this study we evaluated the development of migraine after percutaneous closure of atrial septal defect. An abrupt and excruciating form of migraine developed shortly after shunt closure in 5 of 13 consecutive patients undergoing this procedure. A dramatic relief of pain was achieved almost instantaneously after administration of 300 mg of clopidogrel.